Effects of zaleplon: A Synthesis of Findings from 22 Studies
- Home
- Effects of zaleplon
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of zaleplon: A Synthesis of Findings from 22 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Findings
Studies on zaleplon have shown that it is an effective treatment for insomnia, with minimal residual effects and a lower potential for abuse than other sedatives. 19 , 2 , 17 Zaleplon does not significantly impair driving ability, memory functions, or psychomotor performance. 19 In fact, zaleplon has been shown to be a safe hypnotic with no significant next-morning residual impairment when used in the middle of the night. 19 In comparison to triazolam, zaleplon produced less performance impairment and a shorter period of ethanol potentiation. 2 Research suggests that zaleplon, in contrast to other GABA agonists, has a relatively selective action on GABAA receptors and may be a useful option for treating insomnia in the elderly. 6 However, zaleplon can also cause adverse effects such as somnambulism (sleepwalking) and sleep-eating behavior. 22 Furthermore, research into the forensic toxicology of Z-drugs has revealed that their pharmacokinetic profiles are improved, but they still share a similar incidence of neuropsychiatric sequelae, poisoning, and death as other hypnotics. 20 It is also noteworthy that researchers are exploring novel delivery methods, such as intranasal administration, to enhance the bioavailability and brain-targeted delivery of zaleplon. 4 , 3
Benefits and Risks
Benefits Summary
Zaleplon is effective in treating insomnia and has a low potential for abuse. It does not significantly impair driving, memory, or psychomotor performance and is considered a safe hypnotic. It also has a short duration of action, minimizing the risk of next-day drowsiness. 19 , 2 , 17 Moreover, zaleplon is a viable option for elderly patients with insomnia, as it does not cause rebound insomnia. 6 Research indicates that zaleplon may be effective in treating depression in individuals with HIV. 7
Risks Summary
Zaleplon can cause side effects such as sleepwalking (somnambulism) and sleep-eating behavior. It is important to monitor for these side effects, even in patients without a history of somnambulism. 22 Zaleplon is not without the potential for dependence, particularly when used chronically. 20 Furthermore, zaleplon, like other hypnotics, can pose a risk of death, particularly in cases of overdose. While zaleplon has a more favorable pharmacokinetic profile than benzodiazepines, long-term consequences are still under investigation. 20
Comparison Between Studies
Similarities
Many studies agree that zaleplon is effective in treating insomnia, with minimal residual effects and a low potential for abuse. 19 , 2 , 17 , 6 , 11 The research consistently highlights the benefits of zaleplon in reducing sleep latency and improving sleep quality compared to other hypnotics. 19 , 2 , 17 , 6
Differences
While there is general consensus on zaleplon's effectiveness for insomnia, some studies report contrasting findings regarding specific side effects. For example, some studies have documented adverse effects such as somnambulism (sleepwalking) and sleep-eating behavior, while others have not. 22 Similarly, some studies suggest that zaleplon, like other hypnotics, can lead to dependence, while others indicate a lower risk of dependence. 20 , 11 These differences highlight the need for more extensive and long-term studies to comprehensively understand zaleplon's effects and risks.
Consistency and Contradictions of Results
The research findings on zaleplon demonstrate both consistency and contradictions. There is a general agreement that zaleplon is effective in treating insomnia and has minimal residual effects. 19 , 2 , 17 , 6 However, certain studies highlight adverse effects, such as somnambulism and sleep-eating behavior, which have not been consistently reported across all research. 22 Similarly, the potential for dependence remains a subject of debate. 20 , 11 Further research is necessary to clarify these discrepancies and provide a more comprehensive understanding of zaleplon's full spectrum of effects.
Practical Applications and Considerations
While zaleplon appears to be a promising treatment option for insomnia, it is essential to exercise caution when using it. 19 , 2 , 17 , 6 , 11 , 22 , 20 Due to potential side effects, such as somnambulism and sleep-eating behavior, zaleplon should be used under the supervision of a healthcare professional. 22 Patients should be informed of these risks and monitored closely for any unusual behavior or changes in sleep patterns. 22 Furthermore, the potential for dependence, although considered lower than with some other hypnotics, should not be overlooked. 20 , 11 Long-term use should be carefully considered and discussed with a doctor to assess the benefits and risks.
Limitations of Current Research
The current research on zaleplon is limited in several ways. The majority of studies are short-term, offering limited insights into long-term effects and potential side effects. 19 , 2 , 17 , 6 While zaleplon's safety profile appears favorable compared to other hypnotics, more substantial evidence is needed to confirm its long-term safety and efficacy. 19 , 2 , 17 Furthermore, the potential for dependence and the possibility of developing tolerance to zaleplon remain areas that warrant further investigation. 20 , 11
Future Directions for Research
Future research on zaleplon should focus on long-term effects, particularly in relation to dependence, tolerance development, and any potential for long-term side effects. 19 , 2 , 17 , 6 Further investigation into the mechanisms of action of zaleplon, specifically its interactions with different types of GABAA receptors, is also crucial. 15 , 18 Additionally, exploring novel delivery methods, such as intranasal administration, to optimize bioavailability and brain-targeted delivery could enhance the effectiveness and reduce potential side effects of zaleplon. 4 , 3
Conclusion
Zaleplon appears to be a promising treatment option for insomnia, offering several advantages over other hypnotics. It effectively improves sleep quality and has a low potential for abuse, with minimal residual effects on cognitive function. However, it's crucial to be aware of potential side effects, such as somnambulism and sleep-eating behavior, and to use zaleplon under the guidance of a healthcare professional. Ongoing research is necessary to further clarify its long-term effects, including potential dependence, tolerance, and any long-term side effects. This will enable healthcare providers to provide optimal and informed treatment plans for patients with insomnia. It is important to remember that no medication is without risks and that the decision to use any medication should be made in consultation with a qualified healthcare professional.
Benefit Keywords
Risk Keywords
Article Type
Author: AvramMichael J, SpykerDaniel A, KehneJohn H, CassellaJames V
Language : English
Author: RoehrsT, RosenthalL, KoshorekG, ManganoR M., RothT
Language : English
Author: Abd-ElrasheedEman, El-HelalySara Nageeb, El-AshmoonyManal M, SalahSalwa
Language : English
Author: Abd-ElrasheedEman, Nageeb El-HelalySara, El-AshmoonyManal M, SalahSalwa
Language : English
A visual ERP study of impulse inhibition following a zaleplon-induced nap after sleep deprivation.
Author: ZhangQianru, LiaoYang, QiJianlin, ZhaoYongqi, ZhuTianli, LiuZhaohui, LiuXufeng
Language : English
Author: Ancoli-IsraelSonia, WalshJames K., ManganoRichard M., FujimoriMasamoto
Language : English
Author: GoldschmiedJennifer R, SenguptaArjun, SharmaAnup, TaylorLynne, MoralesKnashawn H, ThaseMichael E, WeljieAalim, KayserMatthew S
Language : English
Author: VolonninoG, La RussaR, Di FazioN, OttavianiM, ZamponiM V, SpadazziF, Umani-RonchiF
Language : English
Author: AmihăeseiIoana Cristina, MungiuO C
Language : English
Author: ZammitGary K., KramerJeffrey A.
Language : English
Author: RushC R, FreyJ M, GriffithsR R
Language : English
Author: RichterGrant, LiaoVivian W Y, AhringPhilip K, ChebibMary
Language : English
Author: YueJing-Li, ChangXiang-Wen, ZhengJun-Wei, ShiLe, XiangYa-Jie, QueJian-Yu, YuanKai, DengJia-Hui, TengTeng, LiYang-Yang, SunWei, SunHong-Qiang, VitielloMichael V, TangXiang-Dong, ZhouXin-Yu, BaoYan-Ping, ShiJie, LuLin
Language : English
Author: SheltonKeith L, NicholsonKatherine L
Language : English
Author: ParonisC A, CoxE D, CookJ M, BergmanJ
Language : English
Author: AtorN A, KautzM A
Language : English
Author: TroyS M, LuckiI, UnruhM A, CevallosW H, LeisterC A, MartinP T, FurlanP M, ManganoR
Language : English
Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
Author: SannaEnrico, BusoneroFabio, TalaniGiuseppe, CartaMario, MassaFederico, PeisMichela, MacioccoElisabetta, BiggioGiovanni
Language : English
Author: VersterJoris C, VolkertsEdmund R, SchreuderAntonia H C M L, EijkenErik J E, van HeuckelumJanet H G, VeldhuijzenDieuwke S, VerbatenMarinus N, PatyIsabelle, DarwishMona, DanjouPhilippe, PatatAlain
Language : English
Author: ZhangYong-zhi, HeHong-yuan, SheCai-meng, LianJie
Language : Chinese
Author: ShuklaLekhansh, BokkaSpandana, ShuklaTulika, KandasamyArun, ChandPrabhat, BenegalVivek, MurthyPratima
Language : English
Author: ChenYen-Wen, TsengPing-Tao, WuChing-Kuan, ChenChien-Chih
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.